Recherche
-
Pharmacological treatment patterns in heart failure: a population-based cohort study
(Eur J Clin Pharmacol. vol. 76, n° 1, pp. 97-106, 2020)Article de revue -
Previous Drug Exposure in Patients Hospitalised for Acute Liver Injury: A Case-Population Study in the French National Healthcare Data System
(Drug safety. vol. 42, n° 4, pp. 559-572, 2019-04)Article de revue -
Effectiveness and Safety of Standard and Reduced Doses of Dabigatran Compared to Rivaroxaban in Nonvalvular Atrial Fibrillation: Long-Term Results from a Cohort Study in the French Nationwide Claims Database
(Journal of the American College of Cardiology. vol. 75, n° 11, pp. 357, 2020)Article de revue -
Empirical assessment of case-based methods for identification of drugs associated with upper gastrointestinal bleeding in the French National Healthcare System database (SNDS)
(Pharmacoepidemiology and Drug Safety. vol. 29, n° 8, pp. 890-903, 2020)Article de revue -
Effectiveness and safety of standard and reduced doses of dabigatran versus rivaroxaban in non-valvular atrial fibrillation: A cohort study in the snds french nationwide claims database
(Value Health. vol. 21, pp. S7-S7, 2018-10)Article de revue -
Benefit-risk profile of dabigatran compared with vitamin-K antagonists in elderly patients with non-valvular atrial fibrillation: results from a cohort study in the French nationwide claims database
(European Heart Journal. vol. 39, pp. 822-822, 2018-08)Article de revue -
Pharmacoepidemiology of non-steroidal anti-inflammatory drugs
(Therapie. vol. 74, n° 2, pp. 271-277, 2019-04)Article de revue -
Drug exposure and risk of Acute Liver Failure leading to registration for liver Transplantation (ALFT): Results of the SALT III study in adults in France
(J. Hepatol.. vol. 68, pp. S587-S588, 2018-04)Article de revue -
Comparative Effectiveness and Safety of Standard or Reduced Dose Dabigatran vs. Rivaroxaban in Nonvalvular Atrial Fibrillation
(Clinical Pharmacology and Therapeutics. vol. 105, n° 6, pp. 1439-1455, 2019)Article de revue -
Correction to: Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS
(American Journal of Cardiovascular Drugs, 2021-12-21)Article de revue